3 Vehicle Interiors Parts Maker, Compact Cars Producer and Additives Chemicals Maker Stocks With a Strong Future Roadmap: Lumax Auto Technologies, Hyundai Motor India and Clean Science and Technology
- November 19, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Lumax Auto Technologies, Hyundai Motor India and Clean Science and Technology: ROE of 14.5% to 27.1% and FY22 to FY26 revenue CAGR of 8.5% to 34.1%. Prices as of 18 Nov 2026.
Quick Answer
The three seat frame, compact SUV and fine chemical stocks to watch are Lumax Auto Technologies, Hyundai Motor India and Clean Science and Technology. Their return on equity ranges from 14.5% to 27.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.5% to 34.1%. Hyundai Motor India has the highest return on equity at 27.1%, while Lumax Auto Technologies has the fastest revenue growth at 34.1% a year. Prices are based on the 18 November 2026 close, and this article is educational, not investment advice.
Seat frame, compact SUV and fine chemical stocks offer a focused view of a sector where demand keeps widening. Lumax Auto Technologies, Hyundai Motor India and Clean Science and Technology cover an auto components maker, a passenger vehicles maker and a performance chemicals maker.
This list covers three seat frame, compact SUV and fine chemical stocks with complete current figures: Lumax Auto Technologies, Hyundai Motor India and Clean Science and Technology. Every figure comes from the latest reported financials and the 18 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Seat Frame, Compact SUV and Fine Chemical Stocks?
Seat frame, compact SUV and fine chemical stocks are listed companies that make mirrors, seat frames and electronic parts for vehicles, make cars and SUVs for India and export markets, and make performance chemicals for paints, cosmetics and polymers. Their earnings depend on vehicle output, car sales and chemical orders.
Seat Frame, Compact SUV and Fine Chemical Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Lumax Auto Technologies | 2,316.1 | 12,977 | 34.0 | 36.9 | 23.0 | 1.02 |
| Hyundai Motor India | 2,097.5 | 150,645 | 30.4 | 23.4 | 27.1 | 0.05 |
| Clean Science and Technology | 698.95 | 8,080 | 34.7 | 35.1 | 14.5 | 0.00 |
On valuation, Lumax Auto Technologies and Clean Science and Technology trade at a P/E below the industry P/E, while Hyundai Motor India trades above it, which reflects the growth the market already expects. Readers comparing seat frame, compact SUV and fine chemical stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in seat frame, compact SUV and fine chemical stocks can use the coming numbers to test whether growth is holding.
Why Do Seat Frame, Compact SUV and Fine Chemical Stocks Have a Strong Roadmap in India?
Seat frame, compact SUV and fine chemical stocks have a strong roadmap in India because steady vehicle output, rising car sales and steady demand for performance chemicals keep widening the market for these companies.
- Auto components. Every vehicle needs seats and mirrors.
- Passenger vehicles. Families upgrade to new cars.
- Performance chemicals. Brands need tailored ingredients.
Why Lumax Auto Technologies Features Among These Seat Frame, Compact SUV and Fine Chemical Stocks
Among the seat frame, compact SUV and fine chemical stocks on this list, Lumax Auto Technologies supplies gear shift systems, plastic components and electronics to two-wheeler and passenger vehicle makers, as part of the Lumax group.
In the June 2026 quarter, revenue grew 32.9% year on year to Rs 1,379 crore, while net profit rose 82.7% to Rs 98.6 crore. Revenue rose from Rs 1,521 crore in FY22 to Rs 4,917 crore in FY26, a compound annual growth rate of 34.1%.
Net profit grew from Rs 81.9 crore in FY22 to Rs 337 crore in FY26, which works out to a compound annual growth rate of 42.5%. The company has a return on equity of 23.0%, a debt to equity ratio of 1.02 and a market capitalisation of Rs 12,977 crore. The stock trades at a P/E of 34.0, below the industry P/E of 36.9.
Roadmap: The company is widening its product range and customer base, including electric vehicle programmes and new categories through joint ventures and acquisitions. Content per vehicle is rising as vehicles add more electronics and plastics, which helps its revenue per unit.
What to watch: Follow integration of new businesses and the pace of electric vehicle orders.
Why Hyundai Motor India Features Among These Seat Frame, Compact SUV and Fine Chemical Stocks
Among the vehicle parts, Korean car brand and specialty inputs shares on this list, Hyundai Motor India is the country’s second largest passenger vehicle maker by volume, selling hatchbacks, sedans and sport utility vehicles from its plant near Chennai and a new facility in Pune.
The company has a return on equity of 27.1%, a debt to equity ratio of 0.05 and a market capitalisation of Rs 150,645 crore. The stock trades at a P/E of 30.4, above the industry P/E of 23.4.
Revenue rose from Rs 47,966 crore in FY22 to Rs 71,752 crore in FY26, a compound annual growth rate of 10.6%. Net profit grew from Rs 2,902 crore in FY22 to Rs 5,432 crore in FY26, which works out to a compound annual growth rate of 17.0%.
Roadmap: A strong sport utility vehicle line-up, a growing exports business and new capacity at the Pune plant add to volumes. The company is also working on electric models and hybrid options for the Indian market.
What to watch: Follow monthly sales, new model launches and the ramp-up of the Pune plant.
Why Clean Science and Technology Features Among These Seat Frame, Compact SUV and Fine Chemical Stocks
Among the three companies on this list, Clean Science and Technology makes specialty chemicals including performance chemicals, pharma intermediates and FMCG chemicals using its own catalytic processes.
Revenue rose from Rs 715 crore in FY22 to Rs 989 crore in FY26, a compound annual growth rate of 8.5%. Net profit for FY26 was Rs 230 crore, a net margin of 23.2%.
In the June 2026 quarter, revenue grew 13.4% year on year to Rs 291 crore, while net profit rose 4.7% to Rs 73.3 crore. The company has a return on equity of 14.5%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 8,080 crore. The stock trades at a P/E of 34.7, below the industry P/E of 35.1.
Roadmap: The company uses cleaner, in-house developed processes that give it cost advantages in products such as MEHQ and guaiacol. It is adding new products and capacity, and carries no debt.
What to watch: Watch new product launches and capacity utilisation at its newer plants.
Lumax Auto Technologies vs Hyundai Motor India vs Clean Science and Technology on Key Financials
The table below sets the three seat frame, compact SUV and fine chemical stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Lumax Auto Technologies | 1,521 | 4,917 | 34.1% | 337 | 6.9% |
| Hyundai Motor India | 47,966 | 71,752 | 10.6% | 5,432 | 7.6% |
| Clean Science and Technology | 715 | 989 | 8.5% | 230 | 23.2% |
Hyundai Motor India posts the highest return on equity in this group at 27.1%. Hyundai Motor India has the largest FY26 revenue at Rs 71,752 crore, and Lumax Auto Technologies shows the fastest revenue growth with a 34.1% compound annual rate. A useful habit with seat frame, compact SUV and fine chemical stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several auto components, passenger vehicles and performance chemicals stocks instead of one name, which keeps a single result from deciding the outcome.
Key Risks to Check Before Investing in Seat Frame, Compact SUV and Fine Chemical Stocks
Every theme carries risks that deserve a check before any decision. For these seat frame, compact SUV and fine chemical stocks, the main points are: Long-term vehicle parts, Korean car brand and specialty inputs shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Demand cycles. Sales can vary with seasons and rates.
- Competition. Rivals can influence pricing and market share.
- Raw material and energy costs. Input prices can move margins in chemicals.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter seat frame, compact SUV and fine chemical stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Seat Frame, Compact SUV and Fine Chemical Stocks
Seat frame, compact SUV and fine chemical stocks reward patient research into demand, execution and financial strength. Lumax Auto Technologies, Hyundai Motor India and Clean Science and Technology each have a clear plan to grow. Based on the 18 November 2026 close, Lumax Auto Technologies trades at Rs 2,316.1, Hyundai Motor India at Rs 2,097.5 and Clean Science and Technology at Rs 698.95. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these seat frame, compact SUV and fine chemical stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track seat frame, compact SUV and fine chemical stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are seat frame, compact SUV and fine chemical stocks?
Ans. Seat frame, compact SUV and fine chemical stocks are listed companies that make mirrors, seat frames and electronic parts for vehicles, make cars and SUVs for India and export markets, and make performance chemicals for paints, cosmetics and polymers. Their earnings depend on vehicle output, car sales and chemical orders. This list looks at three of them, Lumax Auto Technologies, Hyundai Motor India and Clean Science and Technology, using reported FY22 to FY26 financials and the 18 November 2026 closing prices.
Which seat frame, compact SUV and fine chemical stocks are covered in this list?
Ans. This list covers Lumax Auto Technologies, Hyundai Motor India and Clean Science and Technology. Based on the 18 November 2026 close, Lumax Auto Technologies traded at Rs 2,316.1, Hyundai Motor India at Rs 2,097.5 and Clean Science and Technology at Rs 698.95. Their return on equity ranges from 14.5% to 27.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.5% to 34.1%.
Why do seat frame, compact SUV and fine chemical stocks have a strong future roadmap in India?
Ans. Seat frame, compact SUV and fine chemical stocks have a strong roadmap in India because steady vehicle output, rising car sales and steady demand for performance chemicals keep widening the market for these companies. The main drivers are as follows. Auto components. Every vehicle needs seats and mirrors. Passenger vehicles. Families upgrade to new cars. Performance chemicals. Brands need tailored ingredients. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Lumax Auto Technologies performed financially?
Ans. Revenue rose from Rs 1,521 crore in FY22 to Rs 4,917 crore in FY26, a compound annual growth rate of 34.1%. Net profit grew from Rs 81.9 crore in FY22 to Rs 337 crore in FY26, which works out to a compound annual growth rate of 42.5%. In the June 2026 quarter, revenue grew 32.9% year on year to Rs 1,379 crore, while net profit rose 82.7% to Rs 98.6 crore. The company has a return on equity of 23.0%, a debt to equity ratio of 1.02 and a market capitalisation of Rs 12,977 crore. The stock trades at a P/E of 34.0, below the industry P/E of 36.9. Looking ahead, the company is widening its product range and customer base, including electric vehicle programmes and new categories through joint ventures and acquisitions. Content per vehicle is rising as vehicles add more electronics and plastics, which helps its revenue per unit.
How has Hyundai Motor India performed financially?
Ans. Revenue rose from Rs 47,966 crore in FY22 to Rs 71,752 crore in FY26, a compound annual growth rate of 10.6%. Net profit grew from Rs 2,902 crore in FY22 to Rs 5,432 crore in FY26, which works out to a compound annual growth rate of 17.0%. The company has a return on equity of 27.1%, a debt to equity ratio of 0.05 and a market capitalisation of Rs 150,645 crore. The stock trades at a P/E of 30.4, above the industry P/E of 23.4. Looking ahead, a strong sport utility vehicle line-up, a growing exports business and new capacity at the Pune plant add to volumes. The company is also working on electric models and hybrid options for the Indian market.
How has Clean Science and Technology performed financially?
Ans. Revenue rose from Rs 715 crore in FY22 to Rs 989 crore in FY26, a compound annual growth rate of 8.5%. Net profit for FY26 was Rs 230 crore, a net margin of 23.2%. In the June 2026 quarter, revenue grew 13.4% year on year to Rs 291 crore, while net profit rose 4.7% to Rs 73.3 crore. The company has a return on equity of 14.5%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 8,080 crore. The stock trades at a P/E of 34.7, below the industry P/E of 35.1. Looking ahead, the company uses cleaner, in-house developed processes that give it cost advantages in products such as MEHQ and guaiacol. It is adding new products and capacity, and carries no debt.
What risks should investors check before buying seat frame, compact SUV and fine chemical stocks?
Ans. Investors should check a few risks before buying seat frame, compact SUV and fine chemical stocks. Demand cycles. Sales can vary with seasons and rates. Competition. Rivals can influence pricing and market share. Raw material and energy costs. Input prices can move margins in chemicals. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of seat frame, compact SUV and fine chemical stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 18 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.